Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer

Autor Lorch, Jochen H
Vydáno 2009

Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back

Autor Chau, Nicole G., Lorch, Jochen H.
Vydáno v Oncologist (2015)

Induction Chemotherapy for Locoregionally Advanced Head and Neck Cancer: Past, Present, Future?

Autor Hanna, Glenn J., Haddad, Robert I., Lorch, Jochen H.
Vydáno 2013

A case of primary secretory carcinoma of the thyroid with high-grade features

Autor Wu, Elizabeth Y, Lebastchi, Jasmin, Marqusee, Ellen, Lorch, Jochen H, Krane, Jeffrey F, Barletta, Justine A
Vydáno v Histopathology (2017)

Genomic analysis of metastatic cutaneous squamous cell carcinoma

Autor Li, Yvonne Y., Hanna, Glenn J., Laga, Alvaro C., Haddad, Robert I., Lorch, Jochen H., Hammerman, Peter S.
Vydáno v Clin Cancer Res (2015)

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature

Autor Kumar, Vivek, Shinagare, Atul B., Rennke, Helmut G., Ghai, Sandeep, Lorch, Jochen H., Ott, Patrick A., Rahma, Osama E.
Vydáno v Oncologist (2020)

Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer

Autor Hanna, Glenn J., Kacew, Alec, Chau, Nicole G., Shivdasani, Priyanka, Lorch, Jochen H., Uppaluri, Ravindra, Haddad, Robert I., MacConaill, Laura E.
Vydáno v JCI Insight (2018)

Long term results of TAX324, a randomized phase III trial of sequential therapy with TPF versus PF in locally advanced squamous cell cancer of the head and neck

Autor Lorch, Jochen H., Goloubeva, Olga, Haddad, Robert I., Cullen, Kevin, Sarlis, Nicholas, Tishler, Roy, Tan, Ming, Fasciano, John, Sammartino, Daniel E., Posner, Marshall R.
Vydáno v Lancet Oncol (2011)

Trastuzumab for the Treatment of Salivary Duct Carcinoma

Autor Limaye, Sewanti A., Posner, Marshall R., Krane, Jeffrey F., Fonfria, Maria, Lorch, Jochen H., Dillon, Deborah A., Shreenivas, Aditya V., Tishler, Roy B., Haddad, Robert I.
Vydáno 2013

Frameshift events predict anti–PD-1/L1 response in head and neck cancer

Autor Hanna, Glenn J., Lizotte, Patrick, Cavanaugh, Megan, Kuo, Frank C., Shivdasani, Priyanka, Frieden, Alexander, Chau, Nicole G., Schoenfeld, Jonathan D., Lorch, Jochen H., Uppaluri, Ravindra, MacConaill, Laura E., Haddad, Robert I.
Vydáno v JCI Insight (2018)

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

Autor Hanna, Glenn J., Kacew, Alec J., Tanguturi, Anusha R., Grote, Hans J., Vergara, Victoria, Brunkhorst, Beatrice, Rabinowits, Guilherme, Thakuria, Manisha, LeBoeuf, Nicole R., Ihling, Christian, DeCaprio, James A., Lorch, Jochen H.
Vydáno v Front Med (Lausanne) (2020)

The Benefits of Adjuvant Trastuzumab for HER‐2‐Positive Salivary Gland Cancers

Autor Hanna, Glenn J., Bae, Ji Eun, Lorch, Jochen H., Haddad, Robert I., Jo, Vickie Y., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Goguen, Laura A., Annino, Donald J., Chau, Nicole G.
Vydáno v Oncologist (2020)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer

Autor Sridharan, Vishwajith, Margalit, Danielle N, Lynch, Stephanie A, Severgnini, Mariano, Zhou, Jun, Chau, Nicole G, Rabinowits, Guilherme, Lorch, Jochen H, Hammerman, Peter S, Hodi, F Stephen, Haddad, Robert I, Tishler, Roy B, Schoenfeld, Jonathan D
Vydáno v Br J Cancer (2016)

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

Autor Hanna, Glenn J., Rettig, Eleni M., Park, Jong C., Varvares, Mark A., Lorch, Jochen H., Margalit, Danielle N., Schoenfeld, Jonathan D., Tishler, Roy B., Goguen, Laura A., Annino, Donald J., Haddad, Robert I., Uppaluri, Ravindra
Vydáno v Oral Oncol (2021)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Autor Kaufman, Howard L., Russell, Jeffery S., Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D’Angelo, Sandra P., Shih, Kent C., Lebbé, Céleste, Milella, Michele, Brownell, Isaac, Lewis, Karl D., Lorch, Jochen H., von Heydebreck, Anja, Hennessy, Meliessa, Nghiem, Paul
Vydáno v J Immunother Cancer (2018)

Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial

Autor Lu, Weidong, Wayne, Peter M., Davis, Roger B., Buring, Julie E., Li, Hailun, Macklin, Eric A., Lorch, Jochen H., Burke, Elaine, Haddad, Tyler C., Goguen, Laura A., Rosenthal, David S., Tishler, Roy B., Posner, Marshall R., Haddad, Robert I.
Vydáno v Oncologist (2016)

Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment

Autor Zhang, Yuehan, Waterboer, Tim, Haddad, Robert I., Miles, Brett A., Wentz, Alicia, Gross, Neil D., Fakhry, Carole, Quon, Harry, Lorch, Jochen H., Gourin, Christine G., Clayburgh, Daniel, Misiukiewicz, Krzysztof J., Richmon, Jeremy D., Andersen, Peter E., Posner, Marshall R., D’Souza, Gypsyamber
Vydáno v Oral Oncol (2017)

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Autor Kaufman, Howard L, Russell, Jeffery, Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D’Angelo, Sandra P, Shih, Kent C, Lebbé, Céleste, Linette, Gerald P, Milella, Michele, Brownell, Isaac, Lewis, Karl D, Lorch, Jochen H, Chin, Kevin, Mahnke, Lisa, von Heydebreck, Anja, Cuillerot, Jean-Marie, Nghiem, Paul
Vydáno v Lancet Oncol (2016)

The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer

Autor Silva de Morais, Nathalie, Stuart, Jessica, Guan, Haixia, Wang, Zhihong, Cibas, Edmund S, Frates, Mary C, Benson, Carol B, Cho, Nancy L, Nehs, Mathew A, Alexander, Caroline A, Marqusee, Ellen, Kim, Mathew I, Lorch, Jochen H, Barletta, Justine A, Angell, Trevor E, Alexander, Erik K
Vydáno v J Endocr Soc (2019)

SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation

Autor Cabanillas, Maria E, Wirth, Lori J, Sherman, Eric J, Drilon, Alexander, Solomon, Benjamin, Robinson, Bruce G, Lorch, Jochen H, McCoach, Caroline, Patel, Jyoti, Leboulleux, Sophie, Worden, Francis, Owonikoko, Taofeek K, Brose, Marcia S, Taylor, Matthew H, Subbiah, Vivek, Rothenberg, S Michael, Huang, Xin, Zhu, Edward, French, Pearl P, Shah, Manisha H
Vydáno v J Endocr Soc (2020)